The company notified customers this month that it will discontinue Medline brand beds and associated products and exit the ...

Medtech CEOs and consultants advised focusing on a core market and preparing for complex processes in a highly regulated ...

CEO Kevin Lobo said the slowdown in hip and knee procedures is tied to broader economic concerns. The outgoing CEO also ...

The first-of-its-kind transcatheter device treats paravalvular leak after valve replacement surgery, to spare the patient ...

The medical device company’s stock dropped when the market opened Wednesday after it slashed sales and earnings forecasts ...

At AdvaMed’s The MedTech Conference, CEOs from top medical device companies shared how they navigate difficult times, ...

M&A rose, but company valuations declined in the first half of 2026 compared with the year-ago period, according to EY’s ...

Stryker said Monday it has closed its takeover of ZuriMED, adding a device for treating rotator cuff tears to its portfolio.

ResMed CEO Mick Farrell, chair of AdvaMed’s board, said the group plans to come up with standards around privacy, ...

The Millennium deal is the third takeover disclosed by Labcorp in eight days. The flurry of activity began on Oct. 15 when ...

Medtronic said Monday it has received a CE mark for its Vitalis portfolio of cardiac pacemakers. The portfolio features five ...

As the closely watched screening test moves closer to Food and Drug Administration approval, MedTech Dive asked cancer ...